ANIK
What one share of Anika Therapeutics holds
Surgical and Medical Instruments and Apparatus
Founded in 1992, Anika Therapeutics, Inc. (“Anika” or “Company”) is a global leader in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The Company leverages proprietary hyaluronic acid (“HA”) technology to develop highly differentiated products.
Anika Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $8.69 |
|---|---|
| Profit | −$0.27 |
| Capex (buildings and equipment) | $0.39 |
| Free cash flow | $0.04 |
| Cash and investments | $2.87 |
| Book value | $10.26 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $6.84 | $2.15 | $0.93 | $0.69 | — | $15.23 |
| 2017 | $7.53 | $2.11 | $0.60 | $2.11 | — | $17.94 |
| 2018 | $7.19 | $1.27 | $0.32 | $2.06 | — | $18.55 |
| 2019 | $7.97 | $1.89 | $0.20 | $2.38 | — | $20.16 |
| 2020 | $9.17 | −$1.69 | $0.11 | $0.80 | — | $19.01 |
| 2021 | $10.10 | $0.28 | $0.35 | $0.22 | — | $19.88 |
| 2022 | $7.70 | −$1.02 | $0.51 | −$0.21 | — | $19.53 |
| 2023 | $8.24 | −$5.64 | $0.37 | −$0.49 | — | $14.48 |
| 2024 | $8.15 | −$3.83 | $0.53 | −$0.16 | — | $10.68 |
| 2025 | $7.87 | −$0.76 | $0.48 | $0.30 | — | $10.33 |